345 related articles for article (PubMed ID: 34070747)
21. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
[TBL] [Abstract][Full Text] [Related]
22. Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture.
Ponterio E; De Maria R; Haas TL
Front Immunol; 2020; 11():565631. PubMed ID: 33101285
[TBL] [Abstract][Full Text] [Related]
23. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation.
Sethi MK; Kim H; Park CK; Baker MS; Paik YK; Packer NH; Hancock WS; Fanayan S; Thaysen-Andersen M
Glycobiology; 2015 Oct; 25(10):1064-78. PubMed ID: 26085185
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of a set of glycosyltransferase genes in human colorectal cancer.
Kudo T; Ikehara Y; Togayachi A; Morozumi K; Watanabe M; Nakamura M; Nishihara S; Narimatsu H
Lab Invest; 1998 Jul; 78(7):797-811. PubMed ID: 9690558
[TBL] [Abstract][Full Text] [Related]
25. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.
Fu C; Zhao H; Wang Y; Cai H; Xiao Y; Zeng Y; Chen H
HLA; 2016 Dec; 88(6):275-286. PubMed ID: 27679419
[TBL] [Abstract][Full Text] [Related]
26. A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis.
Gupta R; Leon F; Rauth S; Batra SK; Ponnusamy MP
Cells; 2020 Feb; 9(2):. PubMed ID: 32075174
[TBL] [Abstract][Full Text] [Related]
27. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
[TBL] [Abstract][Full Text] [Related]
28. Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA
Zhang C; Wang Z; Yang Z; Wang M; Li S; Li Y; Zhang R; Xiong Z; Wei Z; Shen J; Luo Y; Zhang Q; Liu L; Qin H; Liu W; Wu F; Chen W; Pan F; Zhang X; Bie P; Liang H; Pecher G; Qian C
Mol Ther; 2017 May; 25(5):1248-1258. PubMed ID: 28366766
[TBL] [Abstract][Full Text] [Related]
29. Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis.
Agarwal E; Robb CM; Smith LM; Brattain MG; Wang J; Black JD; Chowdhury S
Oncogene; 2017 Jun; 36(22):3104-3118. PubMed ID: 28068324
[TBL] [Abstract][Full Text] [Related]
30. Transgelin is a poor prognostic factor associated with advanced colorectal cancer (CRC) stage promoting tumor growth and migration in a TGFβ-dependent manner.
Elsafadi M; Manikandan M; Almalki S; Mahmood A; Shinwari T; Vishnubalaji R; Mobarak M; Alfayez M; Aldahmash A; Kassem M; Alajez NM
Cell Death Dis; 2020 May; 11(5):341. PubMed ID: 32393769
[TBL] [Abstract][Full Text] [Related]
31. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
[TBL] [Abstract][Full Text] [Related]
32. Effect of transforming growth factor-beta on decorin and beta1 integrin expression during muscle development in chickens.
Li X; McFarland DC; Velleman SG
Poult Sci; 2006 Feb; 85(2):326-32. PubMed ID: 16523634
[TBL] [Abstract][Full Text] [Related]
33. Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer.
Liao TT; Lin CC; Jiang JK; Yang SH; Teng HW; Yang MH
Theranostics; 2020; 10(14):6095-6112. PubMed ID: 32483441
[No Abstract] [Full Text] [Related]
34. FasR and FasL in colorectal cancer.
Szarynska M; Olejniczak A; Wierzbicki P; Kobiela J; Laski D; Sledzinski Z; Adrych K; Guzek M; Kmiec Z
Int J Oncol; 2017 Sep; 51(3):975-986. PubMed ID: 28766682
[TBL] [Abstract][Full Text] [Related]
35. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
Kasprzak A; Adamek A
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
[TBL] [Abstract][Full Text] [Related]
36. Impact of sidedness of colorectal cancer on tumor immunity.
Takasu C; Nishi M; Yoshikawa K; Tokunaga T; Kashihara H; Yoshimoto T; Shimada M
PLoS One; 2020; 15(10):e0240408. PubMed ID: 33045001
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
[TBL] [Abstract][Full Text] [Related]
38. 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids.
Schnalzger TE; de Groot MH; Zhang C; Mosa MH; Michels BE; Röder J; Darvishi T; Wels WS; Farin HF
EMBO J; 2019 Jun; 38(12):. PubMed ID: 31036555
[TBL] [Abstract][Full Text] [Related]
39. High Diversity of Glycosphingolipid Glycans of Colorectal Cancer Cell Lines Reflects the Cellular Differentiation Phenotype.
Wang D; Madunić K; Zhang T; Mayboroda OA; Lageveen-Kammeijer GSM; Wuhrer M
Mol Cell Proteomics; 2022 Jun; 21(6):100239. PubMed ID: 35489554
[TBL] [Abstract][Full Text] [Related]
40. Global-scale profiling of differential expressed lysine acetylated proteins in colorectal cancer tumors and paired liver metastases.
Shen Z; Wang B; Luo J; Jiang K; Zhang H; Mustonen H; Puolakkainen P; Zhu J; Ye Y; Wang S
J Proteomics; 2016 Jun; 142():24-32. PubMed ID: 27178108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
